MANIFEST Study Examining CPI-0610 @IcahnMountSinai

MANIFEST Study Examining CPI-0610 @IcahnMountSinai

obr

1 week
10 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
Report 0 0
Category:
Description:
John Mascarenhas, MD Associate Professor of Medicine, Myeloproliferative Disorders Program-Division of Hematology/Oncology @IcahnMountSinai shares outcomes from the MANIFEST study investigating CPI-0610 as a monotherapy or add-on to ruxolitinib in patients with myelofibrosis.
Up Next Autoplay